Literature DB >> 9613347

Diagnosing Friedreich's ataxia.

N W Wood1.   

Abstract

Clinical diagnosis is still of the utmost importance and following our review of cases diagnosed using the strict criteria, 100% were homozygous for the expansion. However, now that there is a relatively simple direct genetic test, the diagnosis can be considered in more unusual cases. Genetic testing has been shown to be of value in establishing the correct diagnosis and in directing the appropriate screening tests, including cardiological assessment and blood sugar estimation. Perhaps the most interesting development following identification of the gene is the rapid progress in our understanding of the protein. If, as seems likely, it turns out to be a mitochondrial protein involved in iron transport, it gives cause for hope of effective treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9613347      PMCID: PMC1717493          DOI: 10.1136/adc.78.3.204

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  52 in total

1.  Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia.

Authors:  G Geoffroy; A Barbeau; G Breton; B Lemieux; M Aube; C Leger; J P Bouchard
Journal:  Can J Neurol Sci       Date:  1976-11       Impact factor: 2.104

2.  CEREBRAL GIGANTISM IN CHILDHOOD. A SYNDROME OF EXCESSIVELY RAPID GROWTH AND ACROMEGALIC FEATURES AND A NONPROGRESSIVE NEUROLOGIC DISORDER.

Authors:  J F SOTOS; P R DODGE; D MUIRHEAD; J D CRAWFORD; N B TALBOT
Journal:  N Engl J Med       Date:  1964-07-16       Impact factor: 91.245

3.  No evidence for uniparental disomy as a common cause of Sotos syndrome.

Authors:  M Smith; P Fullwood; Y Qi; S Palmer; M Upadhyaya; T Cole
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

4.  Autism and macrocephaly.

Authors:  R E Stevenson; R J Schroer; C Skinner; D Fender; R J Simensen
Journal:  Lancet       Date:  1997-06-14       Impact factor: 79.321

5.  Autosomal dominant inheritance of Weaver syndrome.

Authors:  A Fryer; C Smith; L Rosenbloom; T Cole
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

6.  Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich's ataxia in 56 patients. Clinical and genetic correlates.

Authors:  P J Lamont; M B Davis; N W Wood
Journal:  Brain       Date:  1997-04       Impact factor: 13.501

7.  Exomphalos-macroglossia-gigantism syndrome in Jamaican infants.

Authors:  M J Thorburn; E S Wright; C G Miller; E H Smith-Read
Journal:  Am J Dis Child       Date:  1970-04

8.  Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome.

Authors:  P Zhang; N J Liégeois; C Wong; M Finegold; H Hou; J C Thompson; A Silverman; J W Harper; R A DePinho; S J Elledge
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

9.  Long-term management of abetalipoproteinaemia. Possible role for vitamin E.

Authors:  D P Muller; J K Lloyd; A C Bird
Journal:  Arch Dis Child       Date:  1977-03       Impact factor: 3.791

10.  Macrocephaly in association with unusual cutaneous angiomatosis.

Authors:  M J Stephan; B D Hall; D W Smith; M M Cohen
Journal:  J Pediatr       Date:  1975-09       Impact factor: 4.406

View more
  3 in total

1.  A novel point mutation in the PMP22 gene in a family with Roussy-Levy syndrome.

Authors:  S Zubair; N R Holland; B Beson; J T Parke; C I Prodan
Journal:  J Neurol       Date:  2008-07-07       Impact factor: 4.849

2.  "Both Sides of the Wheelchair": The Views of Individuals with, and Parents of Individuals with Friedreich Ataxia Regarding Pre-symptomatic Testing of Minors.

Authors:  Georgia C Lowe; Louise A Corben; Rony E Duncan; Grace Yoon; Martin B Delatycki
Journal:  J Genet Couns       Date:  2015-01-17       Impact factor: 2.537

3.  Perceived effectiveness and barriers to physical therapy services for families and children with Friedreich ataxia.

Authors:  Joyce Maring; Earllaine Croarkin; Sylvia Morgan; Margaret Plack
Journal:  Pediatr Phys Ther       Date:  2013       Impact factor: 3.049

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.